Virology News and Research

Latest Virology News and Research

New SARS air filter

Matsushita (Panasonic) has announced its environment-related subsidiary, Matsushita Ecology Systems Co., Ltd., has developed a revolutionary SARS air filter.

15 Jul 2004

Expansion of clinical trial of an experimental West Nile virus (WNV) treatment

The National Institute of Allergy and Infectious Diseases, one of the National Institutes of Health, has expanded its clinical trial of an experimental West Nile virus (WNV) treatment to about 60 sites throughout the United States and Canada.

15 Jul 2004

New guidelines for antiretroviral drugs to prevent the transmission of HIV from mothers to their children

The World Health Organization has published new guidelines underlining the effectiveness of antiretroviral drugs to prevent the transmission of HIV from seropositive mothers to their children.

15 Jul 2004

Action against HIV/AIDS that does not confront gender inequality is doomed to failure

Action against HIV/AIDS that does not confront gender inequality is doomed to failure, according to a report released today by the Joint United Nations Programme on HIV/AIDS (UNAIDS), the United Nations Development Fund for Women (UNIFEM) and UNFPA, the United Nations Population Fund.

15 Jul 2004

Latest findings on HIV pathogenesis at AIDS Conference in Bangkok

At the XVth International AIDS Conference in Bangkok, Thailand, Anthony S. Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases and chief of the NIAID Laboratory of Immunoregulation (LIR), will present his laboratory’s latest findings on how aberrant immune activation underlies HIV pathogenesis.

15 Jul 2004

Quality HIV/AIDS treatment eased through extended agreement about lowest-priced drugs and diagnostics

During the International AIDS Conference in Bangkok, IDA ARV Procurement Services BV and Clinton Foundation announced the agreement that enables developing countries to purchase high-quality AIDS medicines and diagnostics at the lowest available prices.

15 Jul 2004

Drugs and crime are important, yet often neglected factors in the evolution of the HIV/AIDS pandemic

The Executive Director of the United Nations Office on Drugs and Crime (UNODC), Antonio Maria Costa, is participating in the Bangkok International AIDS Conference.

13 Jul 2004

Unprecedented opportunity exists for leaders to act now to protect their citizens from AIDS

Political leaders in Asia and the Pacific have a precious window of opportunity to save millions of people from HIV infection. But to succeed, they will need to drastically increase spending on AIDS and scale up prevention, care and treatment programmes, according to a report by the Asia Pacific Leadership Forum (APLF) on HIV/AIDS and Development.

13 Jul 2004

Yoweri Kaguta Museveni has caused a major divide among participants of the AIDS Conference in Thailand

The president of Uganda, Yoweri Kaguta Museveni has caused a major divide among participants at the 15th International AIDS Conference in Thailand by stating that abstinence and marriage are the best ways to stop the spread of the HIV/AIDS epidemic.

12 Jul 2004

Kofi Annan says, overall countries are simply not doing well enough in the battle against HIV/AIDS

UN Secretary-General Kofi Annan has called on world leaders to strengthen their fight against the HIV/AIDS epidemic sweeping the globe. Mr Annan, speaking at 15th International AIDS Conference, said “overall countries are simply not doing nearly well enough”.

12 Jul 2004

Australia's fight against drug abuse recognised by the Indonesian Government

Australia is pleased that its work in Indonesia fighting drug abuse has been recognised by the Indonesian Government, the Foreign Affairs Parliamentary Secretary, Mrs Chris Gallus, said today.

12 Jul 2004

Australia takes lead on looming HIV/AIDS epidemic by doubling funding

Australia is leading efforts to tackle the looming HIV/AIDS crisis in the region by more than doubling our funding - to $600 million by 2010 - to combat the virus and prevent an African-style tragedy.

12 Jul 2004

Study evaluates effectiveness of LEXIVA/ritonavir and Lopinavir/ritonavir in protease inhibitor

HIV treatment regimens containing the protease inhibitor (PI) LEXIVA® (fosamprenavir calcium) dosed with ritonavir (LEXIVA/r) or lopinavir (LPV) and ritonavir (LPV/r) were effective in suppressing HIV in patients who had failed prior PI-containing regimens, according to information presented at the International AIDS Conference (IAC).

12 Jul 2004

Increasing evidence a virus may play a role in breast cancer

A new study finds increasing evidence a virus may play a role in breast cancer. The study finds nearly three-quarters of a small sample of Tunisian breast cancer patients showed evidence of a virus similar to one known to cause breast cancer in mice, twice the rate seen in women in the United States.

12 Jul 2004

HIV patients treated with antiretroviral therapy early after infection do test negative

UCSF researchers have found that some HIV patients treated with antiretroviral therapy early after infection do test negative, at some point, for the virus. Study findings showed this result in six of 87 patients.

12 Jul 2004

Human antibodies that thwart the SARS virus in mice can be mass-produced quickly

Human antibodies that thwart the SARS virus in mice can be mass-produced quickly using a new laboratory technique developed by an international research team collaborating with the National Institute of Allergy and Infectious Diseases (NIAID).

12 Jul 2004

Increasing levels of growth hormone may be an effective treatment for HIV lipodystrophy

Increasing the body's production of growth hormone may be an effective treatment for HIV lipodystrophy, a syndrome involving the redistribution of fat and other metabolic changes in those receiving combination drug therapy for HIV infection.

11 Jul 2004

Widespread prenatal HIV screening and use of antiretroviral drugs in pregnant HIV-infected women is needed

Rapid testing during labor can enable pregnant women with undocumented HIV status to learn their HIV infection status so they can receive antiretroviral prophylaxis and be referred for comprehensive medical care and follow-up according to a report in the current issue of the Journal of the American Medical Association.

11 Jul 2004

Comparison of antiretroviral therapies shows that tenofovir DF and stavudine are equally effective

Results from a three year double-blinded trial which compared antiretroviral therapies show that the combination regimens of tenofovir DF and stavudine, are equally effective, though tenofovir DF has more favorable outcomes with respect to cholesterol levels and the nervous system.

11 Jul 2004

Nevirapine effective in reducing the risk of transmission of HIV at birth

A drug called nevirapine has been shown to be effective in reducing the risk of transmission of HIV at birth, but combination therapy of nevirapine and zidovudine does not improve outcomes, according to a study published in the current HIV/AIDS Journal of the American Medical Association.

11 Jul 2004

Virology News and Research

Latest Virology News and Research

New SARS air filter

Expansion of clinical trial of an experimental West Nile virus (WNV) treatment

New guidelines for antiretroviral drugs to prevent the transmission of HIV from mothers to their children

Action against HIV/AIDS that does not confront gender inequality is doomed to failure

Latest findings on HIV pathogenesis at AIDS Conference in Bangkok

Quality HIV/AIDS treatment eased through extended agreement about lowest-priced drugs and diagnostics

Drugs and crime are important, yet often neglected factors in the evolution of the HIV/AIDS pandemic

Unprecedented opportunity exists for leaders to act now to protect their citizens from AIDS

Yoweri Kaguta Museveni has caused a major divide among participants of the AIDS Conference in Thailand

Kofi Annan says, overall countries are simply not doing well enough in the battle against HIV/AIDS

Australia's fight against drug abuse recognised by the Indonesian Government

Australia takes lead on looming HIV/AIDS epidemic by doubling funding

Study evaluates effectiveness of LEXIVA/ritonavir and Lopinavir/ritonavir in protease inhibitor

Increasing evidence a virus may play a role in breast cancer

HIV patients treated with antiretroviral therapy early after infection do test negative

Human antibodies that thwart the SARS virus in mice can be mass-produced quickly

Increasing levels of growth hormone may be an effective treatment for HIV lipodystrophy

Widespread prenatal HIV screening and use of antiretroviral drugs in pregnant HIV-infected women is needed

Comparison of antiretroviral therapies shows that tenofovir DF and stavudine are equally effective

Nevirapine effective in reducing the risk of transmission of HIV at birth

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut